Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$1.06 - $2.68 $280,900 - $710,200
-265,000 Closed
0 $0
Q2 2020

Jul 16, 2020

SELL
$13.68 - $20.46 $1.16 Million - $1.74 Million
-85,000 Reduced 24.29%
265,000 $4.26 Million
Q1 2020

Apr 16, 2020

SELL
$14.83 - $26.72 $1.11 Million - $2 Million
-75,000 Reduced 17.65%
350,000 $5.43 Million
Q4 2019

Jan 17, 2020

SELL
$9.77 - $24.6 $244,523 - $615,688
-25,028 Reduced 5.56%
425,000 $10.5 Million
Q3 2019

Oct 16, 2019

SELL
$10.17 - $13.86 $443,930 - $605,002
-43,651 Reduced 8.84%
450,028 $4.64 Million
Q2 2019

Jul 22, 2019

BUY
$11.43 - $15.12 $4.97 Million - $6.57 Million
434,474 Added 733.85%
493,679 $6.2 Million
Q1 2019

Apr 11, 2019

BUY
$5.98 - $13.98 $354,045 - $827,685
59,205 New
59,205 $734,000
Q2 2018

Jul 20, 2018

SELL
$12.85 - $18.45 $2.33 Million - $3.34 Million
-181,291 Closed
0 $0
Q1 2018

Apr 11, 2018

SELL
$12.5 - $19.75 $453,750 - $716,925
-36,300 Reduced 16.68%
181,291 $3.22 Million
Q4 2017

Jan 19, 2018

SELL
$11.55 - $20.1 $216,008 - $375,910
-18,702 Reduced 7.91%
217,591 $2.73 Million
Q3 2017

Oct 13, 2017

BUY
$12.7 - $19.25 $3 Million - $4.55 Million
236,293
236,293 $4.5 Million

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.